An adviser reports shared voting power over 5% of Verrica Pharmaceuticals (VRCA).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Dellora Investments LP and its principal, Kevin Pyun, have reported shared voting and dispositive power over 886,630 shares of Verrica Pharmaceuticals (VRCA), representing 5.2% of the company's outstanding common stock. This disclosure was made in a Schedule 13G filing with the SEC, indicating that the shares are held by private funds and another client advised by Dellora.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.